论文信息 - An open‐label, phase 2 trial of RPI.4610 (angiozyme) in the treatment of metastatic breast cancer - 字舞流文

An open‐label, phase 2 trial of RPI.4610 (angiozyme) in the treatment of metastatic breast cancer

G. Hortobagyi | H. Rugo | W. Urba | J. Ensor | A. Elias | K. Margolin | G. Gordon | D. Weng | P. K. Morrow | R. Murthy